Results 31 to 40 of about 354,255 (314)
The Thyroid in End-Stage Renal Disease
Medicine, 1988 Previous studies of patients with end-stage renal disease (ESRD) indicate that the prevalence of goiter varies from 0 to 58% while that of hypothyroidism ranges from 0 to 9.5%. In addition, altered serum thyroid hormone levels are present in euthyroid patients with ESRD and may be related to nonthyroidal disorders including malnutrition.
E M, Kaptein +6 more
openaire +2 more sources
, 2020 BACKGROUND: The impact of end-stage renal disease (ESRD) on peripheral vascular intervention (PVI) outcome remains incompletely elucidated. OBJECTIVES: We sought to compare the outcome of PVI in dialysis patients with those with normal kidney function ...
Mamas
core +1 more source
Baclofen-Induced Encephalopathy in End Stage Renal Disease
Case Reports in Medicine, 2015 Baclofen is a highly used centrally acting GABA agonist that continues to be an effective therapy for spasticity and chronic hiccups. The renally dependent excretion determines the circulating concentrations and guides effective dosing to decrease ...
Andrew Meillier +2 more
doaj +1 more source
Penile Calciphylaxis in End Stage Renal Disease
Case Reports in Urology, 2013 Calciphylaxis, better described as “Calcific uremic arteriolopathy” (CUA), involves about 1–4% of hemodialysis patients all around the world with high mortality rates. We describe a rare clinical case of CUA in peritoneal dialysis patient associated with
Vincenzo Barbera +6 more
doaj +1 more source
Adiponectin and end-stage renal disease [PDF]
Hormones, 2016 Adiponectin (ADPN) is an adipokine with significant anti-inflammatory, insulin-sensitizing and anti-atherogenic properties, which is generally associated with a beneficial cardiometabolic profile. Paradoxically, end-stage renal disease (ESRD) is characterized by markedly increased plasma ADPN levels and increased cardiovascular risk.
Anastasia, Markaki +2 more
openaire +2 more sources
Increased risk of urothelial cancer in young and middle aged patients with end-stage renal disease
, 2017 Background/Purpose: End-stage renal disease (ESRD) may increase the likelihood of malignancy. The aim of this study is to evaluate the characteristics of increased urothelial cancer (UC) risk in patients with ESRD in Taiwan by a population-based study ...
Wang, Shuo-Meng;Lai, Ming-Nan;Chen, Pau-Chung;Wang, Jung-Der +1 more
core +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Pediatric gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are extremely rare and clinically heterogeneous. Management has largely been extrapolated from adult practice. This European Standard Clinical Practice Guideline (ESCP), developed by the EXPeRT network in collaboration with adult NEN experts, provides (adult) evidence ...
Michaela Kuhlen +23 more
wiley +1 more source
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Objective To compare the efficacy and safety of roxarestat versus recombinant human erythropoietin (rhEPO) in the management of renal anemia in patients undergoing maintenance hemodialysis. Methods This was a prospective, open‐label, randomized controlled trial.
Lingling Chen, Junjie Zhu, Qiaonan Ge
wiley +1 more source
Biopsychosocial Needs of the Patients Post Renal Transplant [PDF]
Egyptian Journal of Health Care, 2019 Renal transplantation is the surgical implantation of a human functioning kidney from either living donor or a cadaver into a patient with end-stage renal failure.
Magda Abd-El-Aziz +2 more
doaj +1 more source
Dietary Protein Intake and Peritoneal Protein Losses in Peritoneal Dialysis Patients
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Introduction Peritoneal dialysis (PD) patients lose protein in their waste dialysate, potentially increasing their risk for malnutrition. We wished to determine whether there was any association between losses and dietary protein intake (DPI). Methods DPI was assessed from 24‐h dietary recall using Nutrics software.
Haalah Shaaker, Andrew Davenport
wiley +1 more source